These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 27422055)

  • 1. Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists.
    Hickman LC; Valentine LN; Falcone T
    Am J Obstet Gynecol; 2016 Oct; 215(4):415-22. PubMed ID: 27422055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.
    Blumenfeld Z; Evron A
    Expert Opin Pharmacother; 2015 May; 16(7):1009-20. PubMed ID: 25826240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients.
    Conte B; Del Mastro L
    Minerva Ginecol; 2017 Aug; 69(4):350-356. PubMed ID: 28398024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
    Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological methods for ovarian function and fertility preservation in women with cancer: A literature review.
    Cvetanovic AS; Lambertini M; Punie K; Matovina Brko GG; Zivkovic ND; Popovic MJ; Milovic Kovacevic MM; Popovic LS
    Oncol Res; 2024; 32(8):1309-1322. PubMed ID: 39055889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies over the use of GnRH agonists for reduction of chemotherapy-induced gonadotoxicity.
    Garrido-Oyarzún MF; Castelo-Branco C
    Climacteric; 2016 Dec; 19(6):522-525. PubMed ID: 27644002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis.
    Elgindy E; Sibai H; Abdelghani A; Mostafa M
    Obstet Gynecol; 2015 Jul; 126(1):187-95. PubMed ID: 26241272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical approaches to preservation of fertility in female cancer patients.
    Del Mastro L; Giraudi S; Levaggi A; Pronzato P
    Expert Opin Pharmacother; 2011 Feb; 12(3):387-96. PubMed ID: 21254946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?
    Rodriguez-Wallberg K; Turan V; Munster P; Oktay K
    Ann Oncol; 2016 Feb; 27(2):357. PubMed ID: 26609009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network.
    Ciccarone M; Hohaus S; Pulsoni A; Cavaceppi P; Franzò S; Fabbri R; Cudillo L; Battistini R; Di Rocco A; Annibali O; Cox MC; Provenzano I; Abruzzese E; Renzi D; Tesei C; Anticoli Borza P; Cuccaro A; Andriani A; D'Elia GM; Facchiano A; Marchetti P; Cantonetti M
    Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13174. PubMed ID: 31571303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury.
    Oktay K; Sönmezer M; Oktem O; Fox K; Emons G; Bang H
    Oncologist; 2007 Sep; 12(9):1055-66. PubMed ID: 17914075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons.
    Dolmans MM; Taylor HS; Rodriguez-Wallberg KA; Blumenfeld Z; Lambertini M; von Wolff M; Donnez J
    Fertil Steril; 2020 Oct; 114(4):725-738. PubMed ID: 33040981
    [No Abstract]   [Full Text] [Related]  

  • 13. Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application.
    Lambertini M; Horicks F; Del Mastro L; Partridge AH; Demeestere I
    Cancer Treat Rev; 2019 Jan; 72():65-77. PubMed ID: 30530271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries.
    Blumenfeld Z
    Oncologist; 2007 Sep; 12(9):1044-54. PubMed ID: 17914074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.
    Lambertini M; Moore HCF; Leonard RCF; Loibl S; Munster P; Bruzzone M; Boni L; Unger JM; Anderson RA; Mehta K; Minton S; Poggio F; Albain KS; Adamson DJA; Gerber B; Cripps A; Bertelli G; Seiler S; Ceppi M; Partridge AH; Del Mastro L
    J Clin Oncol; 2018 Jul; 36(19):1981-1990. PubMed ID: 29718793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility preservation in women with CNS tumors.
    Tosoni A; Balestrini D; Brandes AA
    Expert Rev Anticancer Ther; 2017 May; 17(5):439-445. PubMed ID: 28395560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic ovarian preservation in young women undergoing chemotherapy.
    Chahvar ST; Al-Shawaf T; Tranquilli AL
    Curr Med Chem; 2014; 21(2):223-9. PubMed ID: 24164203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GnRH-analogues for ovarian protection in childhood cancer patients: how adult hypotheses are relevant in prepubertal females.
    Osborne SE; Detti L
    Curr Drug Targets; 2013 Jul; 14(8):856-63. PubMed ID: 23614679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian damage from chemotherapy and current approaches to its protection.
    Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
    Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fertility preservation in adolescents and young adults with cancer].
    Rousset-Jablonski C; Chevillon F; Dhedin N; Poirot C
    Bull Cancer; 2016 Dec; 103(12):1019-1034. PubMed ID: 27817861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.